Ocular Pharmacokinetics
Which of the following factors most significantly affects the ocular penetration of topically applied drugs?
A) Molecular weight of the drug
B) Lipid solubility of the drug
C) pH of the drug solution
D) Viscosity of the drug solution
A) Molecular weight of the drug
Which of the following drugs can potentially increase the systemic absorption of a topically applied ocular medication due to inhibition of cytochrome P450 enzymes?
A) Ketoconazole
B) Atorvastatin
C) Metformin
D) Amlodipine
A) Ketoconazole
Which drug class is typically used to enhance retinal pigment epithelial cell function in patients with retinal degenerative diseases?
A) Antioxidants
B) Calcium channel blockers
C) Beta-agonists
D) Corticosteroids
A) Antioxidants
Which factor most significantly impacts the bioavailability of a drug administered via intravitreal injection?
A) Drug solubility and stability
B) Corneal permeability
C) Tear film stability
D) Systemic circulation rate
A. Drug solubility and stability
Which ocular drug delivery system is most effective for achieving prolonged drug release with minimal side effects?
A) Implantable drug reservoirs
B) Topical eye drops
C) Subconjunctival injections
D) Systemic oral tablets
A) Implantable drug reservoirs
When considering the ocular bioavailability of a drug, which route of administration generally results in the highest concentration of drug in the intraocular fluids?
A) Topical application
B) Intravitreal injection
C) Systemic administration
D) Subconjunctival injection
B) Intravitreal injection
Which of the following is a common adverse effect associated with long-term use of topical corticosteroids in the eye?
A) Increased intraocular pressure
B) Decreased intraocular pressure
C) Allergic conjunctivitis
D) Photophobia
A) Increased intraocular pressure
Which of the following systemic side effects is most likely associated with the use of systemic carbonic anhydrase inhibitors?
A) Metabolic acidosis
B) Hypertension
C) Hyperkalemia
D) Hyperglycemia
A) Metabolic acidosis
A patient on oral anti-glaucoma medication presents with symptoms of dizziness and tinnitus. Which of the following is the most likely cause?
A) Alpha agonists
B) Prostaglandin analogs
C) Beta-blockers
D) Carbonic anhydrase inhibitors
D) Carbonic anhydrase inhibitors
What is the main advantage of using biodegradable polymer-based ocular implants for drug delivery?
A) Reduced systemic absorption
B) Immediate onset of action
C) No need for refills
D) Controlled, sustained release of medication
D) Controlled, sustained release of medication
For a drug that follows first-order kinetics, if the plasma concentration of the drug decreases from 100 mg/L to 50 mg/L in 4 hours, what is the half-life of the drug?
A) 2 hours
B) 4 hours
C) 8 hours
D) 12 hours
B) 4 hours
Which class of drugs can lead to an increase in intraocular pressure by causing a reduction in aqueous humor outflow?
A) Anticholinergics
B) Beta-blockers
C) Alpha agonists
D) Carbonic anhydrase inhibitors
A) Anticholinergics
Which of the following is a serious systemic side effect of using high doses of systemic corticosteroids over a prolonged period?
A) Osteoporosis
B) Hyperlipidemia
C) Hypoglycemia
D) Hypotension
A) Osteoporosis
Which of the following drugs would be most effective in reducing the risk of progression of diabetic retinopathy due to its effect on blood glucose control?
A) Metformin
B) Losartan
C) Amlodipine
D) Hydrochlorothiazide
A) Metformin
Which of the following factors significantly affects the bioavailability of drugs administered via intravitreal injections?
A) Drug molecular weight
B) Patient’s age
C) Ocular surface pH
D) Tear production rate
A) Drug molecular weight
Which of the following is the primary mechanism of action of latanoprost in the treatment of glaucoma?
A) Increases uveoscleral outflow of aqueous humor
B) Decreases aqueous humor production
C) Increases trabecular outflow
D) Decreases episcleral venous pressure
A) Increases uveoscleral outflow of aqueous humor
Which drug is used to manage retinal edema by inhibiting VEGF (vascular endothelial growth factor)?
A) Pilocarpine
B) Timolol
C) Acetazolamide
D) Bevacizumab
D) Bevacizumab
What is the primary therapeutic target of ranibizumab in the treatment of neovascular age-related macular degeneration (AMD)?
A) Vascular Endothelial Growth Factor (VEGF)
B) Platelet-Derived Growth Factor (PDGF)
C) Transforming Growth Factor-beta (TGF-β)
D) Fibroblast Growth Factor (FGF)
A) Vascular Endothelial Growth Factor (VEGF)
Which systemic condition could be exacerbated by the chronic use of topical corticosteroids, especially in high doses?
A) Hypertension
B) Hyperlipidemia
C) Hypoglycemia
D) Hypocalcemia
A) Hypertension
Which of the following interactions would most likely decrease the efficacy of topical cyclosporine A used for dry eye treatment?
A) Concurrent use of topical antibiotics
B) Concurrent use of systemic antibiotics
C) Concurrent use of systemic antihistamines
D) Concurrent use of topical steroids
B) Concurrent use of systemic antibiotics
What is the primary action of atropine when used in ocular therapeutics?
A) Mydriasis
B) Miosis
C) Decrease aqueous humor production
D) Increase corneal permeability
A) Mydriasis
The use of which of the following medications can lead to a significant risk of drug-induced retinopathy?
A) Penicillin
B) Ciprofloxacin
C) Chloroquine
D) Ibuprofen
C) Chloroquine
Which ocular pharmacological agent primarily acts by blocking the H1 histamine receptors to provide relief from allergic conjunctivitis?
A) Latanoprost
B) Timolol
C) Olopatadine
D) Pilocarpine
C) Olopatadine
Which of the following medications is most commonly associated with causing posterior subcapsular cataracts as a long-term side effect?
A) Corticosteroids
B) Antihistamines
C) Antidiabetics
D) Antihypertensives
A) Corticosteroids
Which systemic medication is known to cause retinal pigment epithelial (RPE) abnormalities as a side effect?
A) Hydroxychloroquine
B) Methotrexate
C) Azathioprine
D) Cyclosporine
A) Hydroxychloroquine